<DOC>
	<DOCNO>NCT00836017</DOCNO>
	<brief_summary>This study observational trial measure efficacy onabotulinumtoxinA treat Cervical Dystonia .</brief_summary>
	<brief_title>CD-PROBE : Cervical Dystonia Patient Registry Observation onabotulinumtoxinA Efficacy</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Diagnosed Cervical Dystonia Candidate botulinum toxin type A therapy New physician 's practice , and/or new botulinum toxin type A therapy , inject botulinum toxin type A least 16 week participant another clinical trial investigate botulinum toxin type A cervical dystonia Able follow study instruction complete study activity Patients undergo elective surgery trial period Females pregnant , nursing , plan pregnancy History poor cooperation compliance medical treatment unreliability Any condition situation , investigator 's opinion , place patient significant risk , could confound study data , may interfere patient 's participation study , include limited unstable medical condition</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>